Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• The transforming growth factor-β (TGF-β) signaling pathway plays a complex role in cancer, exhibiting both tumor-suppressive and tumor-promoting functions.
• Effective cancer therapeutic design necessitates a thorough understanding of the TGF-β pathway's diverse functional contexts.

Purpose of the Study:

• To review the molecular mechanisms underlying the TGF-β pathway.
• To elucidate the distinct roles of TGF-β in tumor suppression and promotion.
• To assess current data on targeting the TGF-β pathway for cancer treatment.

Main Methods:

• Literature review of molecular mechanisms.
• Analysis of TGF-β's dual roles in tumorigenesis.
• Assessment of preclinical and clinical trial data for TGF-β inhibitors.

Main Results:

• Detailed discussion of the molecular intricacies of the TGF-β signaling cascade.
• Explanation of how TGF-β can both inhibit and drive tumor progression.
• Updated information on TGF-β inhibitors evaluated in preclinical studies and Phase I/II clinical trials.

Conclusions:

• Targeting the TGF-β pathway presents a promising, albeit complex, strategy for cancer therapy.
• Further research and clinical evaluation are essential to fully leverage TGF-β inhibitors in oncology.